Download MendeleyNatural Product-like Fragments Unlock Novel Chemotypes for a Kinase Target─Exploring Options beyond the Flatland.
Santura, A., Muller, J., Wolter, M., Tutzschky, I.C., Ruf, M., Metz, A., Sandner, A., Merkl, S., Klebe, G., Glinca, S., Czodrowski, P.(2025) J Chem Inf Model
- PubMed: 41430555
- DOI: https://doi.org/10.1021/acs.jcim.5c01952
- Primary Citation of Related Structures:
9RDU, 9RDV, 9RDW, 9RDX, 9RDY, 9RDZ, 9RE0, 9RE1, 9RE2, 9RE3, 9RE4, 9RE5, 9RE6, 9RE7, 9RE8, 9RE9, 9REA, 9REB, 9REC, 9RED, 9REE, 9REF, 9REG, 9REH, 9REI, 9REJ, 9REK, 9REL, 9REM, 9REN, 9REO, 9REP, 9REQ, 9RER, 9RES, 9RET - PubMed Abstract:
In this study, we utilized a high-performance soaking system of protein kinase A (PKA) to perform a crystallographic screening of a natural product-like fragment library. We resolved 36 fragment-bound structures, corresponding to a hit rate of 41%. Nine fragments bound within the ATP site, nine peripherally, and 18 interacted with both the ATP and peripheral sites. One fragment binds to the same site as the approved allosteric kinase inhibitor asciminib, while another induces an unexpected conformational change. Systematic database mining revealed that both the fragments and their natural product parents have not been previously associated with PKA or kinase activity. A scaffold/chemotype analysis further underscored their novelty. Cheminformatics analyses confirmed that these fragments occupy a distinct chemical space, enriched in saturation, spatial complexity and molecular three-dimensional character compared to kinase binders from reference data sets. These properties have previously been linked to increased selectivity, reduced CYP450 inhibition, and higher overall clinical success rates.
- Johannes Gutenberg University Mainz, Department of Chemistry, Duesbergweg 10-14, Mainz 55128, Germany.
Organizational Affiliation:
